Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Heartflow (HTFL) Research & Development (2024 - 2025)

Heartflow has reported Research & Development over the past 2 years, most recently at $18.7 million for Q4 2025.

  • For Q4 2025, Research & Development rose 52.01% year-over-year to $18.7 million; the TTM value through Dec 2025 reached $63.3 million, changed N/A, while the annual FY2025 figure was $64.9 million, 49.18% up from the prior year.
  • Research & Development for Q4 2025 was $18.7 million at Heartflow, up from $17.3 million in the prior quarter.
  • Over five years, Research & Development peaked at $18.7 million in Q4 2025 and troughed at $9.9 million in Q2 2024.